Robert F. Booth insider trades

Open-market stock purchases and sales by Robert F. Booth, Director at Summit Therapeutics Inc, from SEC Form 4 filings since Dec 9, 2010.

Recent trades

DateStockTradeValue
Jan 2, 2026SMMT Summit Therapeutics IncBought (not open market)$62.9K
Jan 2, 2026SMMT Summit Therapeutics IncBought (not open market)$613K

Companies traded

  • SMMT Summit Therapeutics Inc: other filings, last Jan 2, 2026
  • CBAY CymaBay Therapeutics, Inc: other filings, last Jan 29, 2019
  • PCYC Pharmacyclics Inc: other filings, last May 26, 2015

Get free alerts when Robert F. Booth files a new trade →